Evidence for its effects on the Wnt/β-catenin pathway remains relatively limited; however, melanoma cell studies showed that fisetin treatment reduces GSK3β phosphorylation, decreases β-catenin stability, and thereby suppresses the EMT phenotype [45]. Here, GSK3B is linked to melanoma.